Study Stopped
Decision was made by Sponsor to stop the trial.
A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer
1 other identifier
observational
4
1 country
4
Brief Summary
The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2011
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 2, 2012
CompletedFirst Posted
Study publicly available on registry
May 4, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedMarch 6, 2015
March 1, 2015
1.2 years
May 2, 2012
March 4, 2015
Conditions
Keywords
Eligibility Criteria
Small cell lung cancer patients undergoing treatment.
You may qualify if:
- Age ≥ 18
- Confirmed diagnosis of SCLC or mixed SCLC/non-SCLC per histopathology results
- Scheduled to undergo first-, second- or third-line treatment for SCLC, including chemotherapy, chemotherapy + radiation therapy, or combined concurrent chemoradiotherapy.
- Able to understand and willing to provide Informed Consent
You may not qualify if:
- No diagnosis of SCLC
- Not scheduled to undergo treatment for the diagnosis of SCLC
- Unable to provide Informed Consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fujirebio Diagnostics, Inc.lead
- Medical Research Networx LLCcollaborator
Study Sites (4)
Kelly Family Medical Center, PC
Eastpointe, Michigan, 48021, United States
St.Louis Cancer Care, LLP
Bridgeton, Missouri, 63044, United States
Heartland Regional Medical Center
Saint Joseph, Missouri, 64506, United States
Hematology Oncology Consultants, Inc.
St Louis, Missouri, 63136, United States
Biospecimen
Collection of whole blood and urine.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2012
First Posted
May 4, 2012
Study Start
May 1, 2011
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
March 6, 2015
Record last verified: 2015-03